Related Experiment Video
Updated: Apr 22, 2026

08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
9.8K
Monoclonal antibodies to HLA-DR antigens
1Department of Clinical Immunology, Flinders Medical Centre, Bedford Park, South Australia 5042.
Immunology Today
|October 8, 2014
Summary
Researchers initiated an information exchange for monoclonal antibodies (Mabs) targeting human MHC class-II antigens. Over 100 Mabs were screened to classify these critical reagents for future research.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Monoclonal antibodies (Mabs) are essential tools for studying human MHC class-II (la-like) antigens.
- Standardization and classification of anti-MHC class-II Mabs are crucial for advancing research in this area.
Purpose of the Study:
- To establish an information exchange scheme for anti-MHC class-II Mabs.
- To classify and group over 100 Mabs from multiple laboratories.
Main Methods:
- Screening of over 100 Mabs from 25 laboratories.
- Utilized various serological, biochemical, and functional assays for Mabs characterization.
- Data compilation and discussion occurred at a dedicated workshop.
Main Results:
- Successfully screened a large cohort of anti-MHC class-II Mabs.
- Initiated a collaborative effort to classify and group these valuable reagents.
- Laid the groundwork for standardized use of Mabs in MHC class-II research.
Conclusions:
- The information exchange scheme facilitated the classification of anti-MHC class-II Mabs.
- Collaborative efforts are vital for advancing the study of human MHC class-II antigens.
- Standardized reagents enhance the reliability and reproducibility of immunological research.
More Related Videos
Related Concept Videos
Hybridoma Technology
13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K
Antigens Involved in Adaptive Immunity
1.7K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K

